Skip to content
Screener

Pre-Tax Income at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$1.92B
Danaher logo
DanaherDHR
$1.08B+64.6%
Azenta logo
AzentaAZTA
$846K-63.3%
Agilent Technologies logo
Agilent TechnologiesA
$408M+56.9%
Illumina logo
IlluminaILMN
$260M-15.0%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$58.97M-62.2%

Segments

By segment

See full
Reportable Segment-$43.98M-12.3%

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$6.84B+338%
Enterprise value$6.83B+370%
P/S16.7×+12.4×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0001581280-26-000040
(In thousands, except per share data)Three months ended March 31, 2026Three months ended March 31, 2025Six months ended March 31, 2026Six months ended March 31, 2025
Loss from operations$(45,863)$(41,560)$(78,763)$(76,205)
Interest income1,7102,8013,8856,041
Other income (expense), net[1]175(394)646(487)
Loss before income taxes$(43,978)$(39,153)$(74,232)$(70,651)
Income tax expense(43)(175)(296)(271)
Net loss$(44,021)$(39,328)$(74,528)$(70,922)
Other comprehensive loss:
Change in unrealized gain (loss) on investments$(85)$30$(67)$97

Item 1. Financial Statements (unaudited)

FAQ

What is Twist Bioscience Corporation's pre-tax income?
Twist Bioscience Corporation (TWST) reported pre-tax income of -$43.98M in Q1 2026.
How has Twist Bioscience Corporation's pre-tax income changed year-over-year?
Twist Bioscience Corporation's pre-tax income decreased by 12.3% year-over-year, from -$39.15M to -$43.98M.
What is the long-term trend for Twist Bioscience Corporation's pre-tax income?
Over 4 years (2021 to 2025), Twist Bioscience Corporation's pre-tax income has grown at a -15.9% compound annual growth rate (CAGR), from -$154.03M to -$76.95M.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Ask your AI about Twist Bioscience Corporation's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude